Consumer healthcare market seen topping $2.1 trillion by 2030

The Business Research Company says the global consumer healthcare market will reach $2,166 billion by 2030, driven by self-care, preventive health, and digital channels. OTC pharmaceuticals are expected to remain the largest segment, while North America and the U.S. lead regional growth.

Why it matters: - Consumer healthcare is moving from a niche category to a major global health spending segment. - The market’s growth signals rising demand for self-care, preventive products, and easier access to everyday health solutions. - OTC pharmaceuticals and dietary supplements are emerging as the biggest growth engines.

What happened: - The Business Research Company released its Consumer Healthcare Market Report 2026 with a forecast through 2035. - The report says the consumer healthcare market will surpass $2,166 billion by 2030. - The market is projected to grow at a 21% compound annual growth rate through 2030. - Consumer healthcare will account for close to 19% of the broader healthcare services market, which is projected to reach $11,335 billion by 2030.

The details: - North America is expected to remain the largest regional market in 2030 at $810 billion, up from $300 billion in 2025. - North America’s projected growth rate is 22%. - The U.S. is forecast to lead globally with a $741 billion market in 2030, up from $274 billion in 2025. - The U.S. growth rate is also projected at 22%. - OTC pharmaceuticals are forecast to be the largest product segment in 2030, representing 58% of the market, or $1,247 billion. - The market is also divided into dietary supplements, retail, online, and hospital distribution channels, and children, adult, and senior end users. - The report says consumer health growth is being driven by health consciousness, preventive care, lifestyle-related illness, and wider use of e-commerce and digital health tools. - The report estimates health-conscious behavior will add about 2.5% annual growth. - Lifestyle-related disorders such as obesity, diabetes, hypertension, digestive issues, and stress-related conditions are projected to add around 2.2% annual growth. - Digital and e-commerce channels are estimated to contribute roughly 2.0% annual growth. - OTC pharmaceuticals and dietary supplements are expected to add more than $1,347 billion in market value by 2030. - The OTC pharmaceuticals segment is projected to grow by $758 billion between 2025 and 2030. - Dietary supplements are projected to grow by $589 billion over the same period.

Between the lines: - The report points to a fragmented market, with the top 10 companies accounting for only 5% of 2025 revenue. - Abbott Laboratories held the largest individual share in 2025 at 1%. - Unilever PLC, Procter & Gamble Co., Haleon, Kenvue Inc. (Johnson & Johnson), Bayer AG, and Reckitt Benckiser Group plc each held 1% shares. - Nestlé SA, Colgate-Palmolive Company, and Sanofi S.A. each held 0.5% shares. - Low-to-moderate barriers to entry suggest competition is shaped by brand strength, distribution, regulation, and product innovation. - Probiotic-based digestive health products are becoming a notable trend in preventive care. - Bayer AG introduced Alka-Seltzer in India in June 2026, combining Ayurvedic effervescent powder with Lactobacillus probiotics. - The report highlights digital health integration, partnerships, product development, and expansion into emerging markets as likely competitive strategies.

What's next: - The market is expected to keep expanding as consumers seek more accessible, personalized, and preventive health products. - Companies are likely to keep investing in OTC offerings, digital health platforms, AI-enabled personalization, and direct-to-consumer channels. - Growth in emerging markets and new product formats could reshape market share over time. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics, and updated graphics for its 2026 edition.

The bottom line: - Consumer healthcare is projected to become a roughly $2.2 trillion market by 2030, with OTC products and digital access driving the next wave of growth. - More information